DAWN — DAY ONE BIOPHARMACEUTICALS I

Name: DAWN Ownership History — SUMMIT SECURITIES GROUP LLC
Creator: 13Foresight
License: https://creativecommons.org/licenses/by/4.0/

Ownership history in SUMMIT SECURITIES GROUP LLC · 1 quarter on record

This page tracks every 13F SEC filing in which SUMMIT SECURITIES GROUP LLC reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	INITIATED	807	—	—	0.00%	$6K	$7.05

% of Fund (quarterly) DAWN price (monthly, adj. close)

Other funds also holding DAWN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 6.91% AIGH Capital Management LLC 3Y 4.49% DAFNA Capital Management LLC 3Y 7Y 2.16% Lion Point Capital, LP 3Y 7Y 2.03% Vestal Point Capital, LP 1.65% Stonepine Capital Management, LLC 3Y 7Y 1.36% MAK CAPITAL ONE LLC 3Y 7Y 0.85% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 0.62% Parkman Healthcare Partners LLC 3Y 0.57% ORACLE INVESTMENT MANAGEMENT INC 3Y 7Y 0.55%

← Back to SUMMIT SECURITIES GROUP LLC Holdings

👋

Welcome to 13Foresight!

We track 13F filings from thousands of hedge funds and alert you when your followed funds file new positions.

Keep me updated — notify me about new 13F filings from funds I follow, and occasional product updates (once a month max).